Clinical Trial: Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental Disorders

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755098) titled 'Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental Disorders' on Aug. 05.

Brief Summary: Neurodevelopmental disorders (NDDs), including intellectual disability (ID), represent the most common indication for genetic testing. Affecting up to 3% of the general population, NDDs are characterized by significant clinical and genetic heterogeneity. Although short-read genome sequencing (srGS) has driven major advances through the France Genomic Medicine 2025 Plan (PFMG2025), a substantial proportion of patients still lack a molecular diagnosis.

These results are partly explained by the limita...